Cargando…
From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors
Aromatase inhibitors (AI) are extensively used as adjuvant endocrine therapy in post-menopausal women with hormone receptor-positive early breast cancer (HR+ EBC), but their impact on bone health is not negligible. This work aimed to assess bone loss, fracture incidence, and risk factors associated...
Autores principales: | Vasconcelos de Matos, Leonor, Fernandes, Leonor, Neves, Maria Teresa, Alves, Fátima, Baleiras, Mafalda, Ferreira, André, Giesteira Cotovio, Pedro, Dias Domingues, Tiago, Malheiro, Mariana, Plácido, Ana, Miranda, Maria Helena, Martins, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025750/ https://www.ncbi.nlm.nih.gov/pubmed/33652975 http://dx.doi.org/10.3390/curroncol28020104 |
Ejemplares similares
-
Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer
por: Miranda Baleiras, Mafalda, et al.
Publicado: (2023) -
Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer
por: Cardoso, Debora, et al.
Publicado: (2020) -
Metastatic extramammary paget disease, a remarkable clinical case and a brief review of a rare disease
por: Fernandes, Leonor, et al.
Publicado: (2020) -
Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
por: Alves, Fátima R, et al.
Publicado: (2022) -
Therapeutic Futility in Terminal Cancer Patients: A Retrospective and Observational Study
por: Graça, Joana, et al.
Publicado: (2021)